Patient-Reported Outcomes in Cancer Care - Zeena NackerdienZeena Nackerdien
PROs should be integral to evidence-based cancer care. Here I summarize the latest expert opinions on the subject in the form of a conversation between two oncologists. This information should be helpful to healthcare practitioners and patients alike. As always, please consult your own medical doctors for case-by-case advice.
Value of Medical Laboratory Science Personnel and Clinical Laboratory Service...Sheleste Vergara
Web-Based Presentation by:
Sheleste Anne Marie R. Vergara
BMLS - 1B
American Society for Clinical Laboratory Science, House of Delegates. ASCLS Position Paper: Patient Safety and Clinical Laboratory Science [Internet]. 2015 Jul [cited 14 Dec 2020]
https://ascls.org/value-of-clinical-laboratory-services/
Patient-Reported Outcomes in Cancer Care - Zeena NackerdienZeena Nackerdien
PROs should be integral to evidence-based cancer care. Here I summarize the latest expert opinions on the subject in the form of a conversation between two oncologists. This information should be helpful to healthcare practitioners and patients alike. As always, please consult your own medical doctors for case-by-case advice.
Value of Medical Laboratory Science Personnel and Clinical Laboratory Service...Sheleste Vergara
Web-Based Presentation by:
Sheleste Anne Marie R. Vergara
BMLS - 1B
American Society for Clinical Laboratory Science, House of Delegates. ASCLS Position Paper: Patient Safety and Clinical Laboratory Science [Internet]. 2015 Jul [cited 14 Dec 2020]
https://ascls.org/value-of-clinical-laboratory-services/
Presentasi yang saya bawakan dalam pelatihan "Strategi Penggunaan ICD-10 dan ICD-9 CM dalam Mendukung BPJS" yang diadakan oleh RS Panti Nugroho, Sabtu, 8 Mei 2014. Semoga bermanfaat.
Using the Bigtown Simulation Model to Predict the Impact of Enhanced Seven Day Services on Hospital Performance and Patient Outcomes
Poster from the 'Delivering NHS services, seven days a week' event held in Birmingham on 16 November 2013
More information about this event can be found at
http://www.nhsiq.nhs.uk/news-events/events/nhs-services-seven-days-a-week.aspx
Kathryn Phillips, PhD presents "Value of Personalized Health Care: What is it? How to measure it? Why Care" at the 2009 Personalized Health Care National Conference at Ohio State University.
Dr. Phillips is Professor of Health Economics and Health Services Research and director/founder of the Center for Translational and Policy Research on Personalized Medicine at the University of California San Francisco.
Decision aids help patients and clinicians decide on the best course of treatment, incorporating evidence from systematic reviews, patient values, individual risk factors, and expert recommendations, all in an intuitive and interactive format.
Patient-based evidence from the patient perspective jangeissler
"Patient-based evidence from the patient perspective", presented on 27 June 2014 by Jan Geissler, CML Advocates Network, at Novartis Global Patient Forum, Basel
April 18, 2018
Decision aids can be highly-effective tools to promote shared decision making and support patients in becoming engaged participants in their healthcare. Join us for the first-ever convening with leaders behind a Washington experiment in certifying decision aids, as state officials, health systems, and on-the-ground implementation experts share lessons learned and discuss policy recommendations for national or statewide approaches to decision aid certification.
For more information, visit our website at: http://petrieflom.law.harvard.edu/events/details/decision-aids-for-patients-with-serious-illness
We illustrate the application of composite material in aerospace industry. Composites are highly efficient to make the parts and structure of aircrafts. We found the characteristics of the composite material make it very suitable material for aerospace industry. Composites like carbon fiber, carbon epoxy, and glass epoxy are very light and high strength which is mostly used in aircraft industries. In addition, our study takes the first step to highlight the uses of composite material to manufacture the different parts of aircrafts.
Presentasi yang saya bawakan dalam pelatihan "Strategi Penggunaan ICD-10 dan ICD-9 CM dalam Mendukung BPJS" yang diadakan oleh RS Panti Nugroho, Sabtu, 8 Mei 2014. Semoga bermanfaat.
Using the Bigtown Simulation Model to Predict the Impact of Enhanced Seven Day Services on Hospital Performance and Patient Outcomes
Poster from the 'Delivering NHS services, seven days a week' event held in Birmingham on 16 November 2013
More information about this event can be found at
http://www.nhsiq.nhs.uk/news-events/events/nhs-services-seven-days-a-week.aspx
Kathryn Phillips, PhD presents "Value of Personalized Health Care: What is it? How to measure it? Why Care" at the 2009 Personalized Health Care National Conference at Ohio State University.
Dr. Phillips is Professor of Health Economics and Health Services Research and director/founder of the Center for Translational and Policy Research on Personalized Medicine at the University of California San Francisco.
Decision aids help patients and clinicians decide on the best course of treatment, incorporating evidence from systematic reviews, patient values, individual risk factors, and expert recommendations, all in an intuitive and interactive format.
Patient-based evidence from the patient perspective jangeissler
"Patient-based evidence from the patient perspective", presented on 27 June 2014 by Jan Geissler, CML Advocates Network, at Novartis Global Patient Forum, Basel
April 18, 2018
Decision aids can be highly-effective tools to promote shared decision making and support patients in becoming engaged participants in their healthcare. Join us for the first-ever convening with leaders behind a Washington experiment in certifying decision aids, as state officials, health systems, and on-the-ground implementation experts share lessons learned and discuss policy recommendations for national or statewide approaches to decision aid certification.
For more information, visit our website at: http://petrieflom.law.harvard.edu/events/details/decision-aids-for-patients-with-serious-illness
We illustrate the application of composite material in aerospace industry. Composites are highly efficient to make the parts and structure of aircrafts. We found the characteristics of the composite material make it very suitable material for aerospace industry. Composites like carbon fiber, carbon epoxy, and glass epoxy are very light and high strength which is mostly used in aircraft industries. In addition, our study takes the first step to highlight the uses of composite material to manufacture the different parts of aircrafts.
Using the scholar data and researcher point of view on composite materials. We illustrate the application of composite material in aerospace industry. Composites are highly efficient to make the parts and structure of aircrafts. We found the characteristics of the composite material make it very suitable material for aerospace industry. Composites like carbon fiber, carbon epoxy, and glass epoxy are very light and high strength which is mostly used in aircraft industries. In addition, our study takes the first step to highlight the uses of composite material to manufacture the different parts of aircraft's.
”DVT Prevention What Works BestSHINE BELL, .docxodiliagilby
“
”
DVT Prevention:
What Works Best?
SHINE BELL, RN, LACEY KEITH, LPN, AMBER MCGRAW, RN, REGAN WENTZ, RN.
FACULTY CONSULT: JAMIE MORRIS, MS RN
OU College of Nursing: Degree Completion
Evidence-Based Practice Symposium
Friday, April 26. 2019
Objective
To analyze and critique current research
regarding the most effective means of
DVT prophylaxis.
PICO Question
For Deep Vein Thrombosis (DVT) prophylaxis, which intervention,
mechanical, pharmacological or combination, best decreases
DVT occurrence in the acute care setting?
Population: Patients in the Acute Care Setting
Intervention: DVT Prophylaxis
Comparison: Mechanical vs Pharmacological vs Combination
Outcome: Decrease of DVT occurrence
What is the Problem?
No current standardized practice guideline for DVT
prevention.
DVT prophylaxis is not implemented correctly in all patients
for whom it is ordered.
There is currently no consensus regarding the preferred
pharmacological therapeutic agent.
Why is this a Problem?
As many as 70% of healthcare-associated blood clots are preventable, yet
fewer than half of hospitalized patients receive appropriate preventive
treatment (CDC, 2018).
Almost all patients admitted to the hospital are at risk for developing a DVT
(Sachdeva, 2018).
DVT is the single most important preventable cause of morbidity and
mortality in many surgical specialties (Chibbaro, 2018).
Without prophylaxis, DVT occurs in 40–60 percent of postoperative cases in
the 7–14 days following surgery (AHRQ, 2012).
Literature Review
Database Search: PubMed, CINAHL, Ovid, Joanna
Briggs
Key terms included: Deep Vein Thrombosis, prophylaxis,
mechanical, pharmacological, DVT best practice, DVT
acute care setting.
Articles used are between the years 2012-2018
Literature Review & Conclusions
Bala et al (2017)
A large database analysis asking (1) What are the differences in VTE incidence in primary
TKA after administration of aspirin, warfarin, enoxaparin, or factor Xa inhibitors? (2) What
are the differences in bleeding risk among these four agents? (3) How has use of these
agents changed with time? Concluded that utilization trends for these agents are not
well-studied.
Beitland et al (2015)
A systematic review with meta-analysis and trial sequential analysis of randomized
controlled trials (RCTs) comparing pharmacological thromboprophylaxis with low
molecular weight heparin (LMWH) versus unfractionated heparin (UFH) in ICU patients.
Concluded a need for future trials.
Chibbaro et al (2018)
A prospective comparative study analyzing results from two separate prophylaxis
protocols implemented in a European neurosurgical center to assess the safety and
efficacy of prevention. Concluded that mechanical devices are non-negligible support
in the prophylaxis of clinically symptomatic DVT.
Literature Review & Conclusions
O'Brien et al (2018)
A two-stage sequential multi ...
Johns Hopkins Hospital doctors report that 40%-80% of chronic pain patient are misdiagnosed, and that MRIs and CTs miss pathology 56%-78% of the time, Therefore, during extensive chart reviews of current medical data will produce a classic case of GIGO-garbage in giving garbage out. The need for accurate diagnoses and testing is critical for AI to work.
How to cite this articlePrado CBC, Machado EAS, Mendes KDS.docxpauline234567
How to cite this article
Prado CBC, Machado EAS, Mendes KDS, Silveira RCCP, Galvão CM. Support surfaces for intraoperative
pressure injury prevention: systematic review with meta-analysis. Rev. Latino-Am. Enfermagem. 2021;29:e3493.
[Access
daymonth year
]; Available in:
URL
. DOI: http://dx.doi.org/10.1590/1518-8345.5279.3493
* Paper extracted from doctoral dissertation “Support surfaces
for prevention for pressure ulcer in the intraoperative
period: systematic review with meta-analysis”, presented
to Universidade de São Paulo, Escola de Enfermagem de
Ribeirão Preto, PAHO/WHO Collaborating Centre for Nursing
Research Development, Ribeirão Preto, SP, Brazil.
1 Universidade de Uberaba, Ciências da Saúde, Uberaba,
MG, Brazil.
2 Universidade de São Paulo, Escola de Enfermagem de
Ribeirão Preto, PAHO/WHO Collaborating Centre for Nursing
Research Development, Ribeirão Preto, SP, Brazil.
3 Scholarship holder at the Conselho Nacional de
Desenvolvimento Científico e Tecnológico/Ministério da
Ciência, Tecnologia e Inovações, Brazil.
Support surfaces for intraoperative pressure injury prevention:
systematic review with meta-analysis*
Objective: to evaluate evidence on effectiveness support
surfaces for pressure injury prevention in the intraoperative
period. Method: systematic review. The search for primary
studies was conducted in seven databases. The sample
consisted of 10 studies. The synthesis of the results was carried
out descriptively and through meta-analysis. Results: when
comparing low-tech support surfaces with regular care (standard
surgical table mattress), the meta-analysis showed that there is
no statistically significant difference between the investigated
interventions (Relative Risk = 0.88; 95%CI: 0.30-2.39). The
Higgins inconsistency test indicated considerable heterogeneity
between studies (I2 = 83%). The assessment of the certainty
of the evidence was very low. When comparing high-tech and
low-tech support surfaces, the meta-analysis showed that there
is a statistically significant difference between the interventions
studied, with high-tech being the most effective (Relative Risk
= 0.17; 95%CI: 0.05-0.53). Heterogeneity can be classified
as not important (I2 = 0%). The assessment of certainty of
evidence was moderate. Conclusion: the use of high-tech
support surfaces is an effective measure to prevent pressure
injuries in the intraoperative period.
Descriptors: Perioperative Nursing; Pressure Ulcer; Systematic
Review; Meta-Analysis; Intraoperative Period; Equipment and
Supplies.
Review Article
Rev. Latino-Am. Enfermagem
2021;29:e3493
DOI: 10.1590/1518-8345.5279.3493
www.eerp.usp.br/rlae
Carolina Beatriz Cunha Prado1
https://orcid.org/0000-0002-4570-9502
Elaine Alves Silva Machado1
https://orcid.org/0000-0002-3683-6438
Karina Dal Sasso Mendes2
https://orcid.org/0000-0003-3349-2075
Renata Cristina de Campos Pereira Silveira2
https://orcid.org/0000-00.
Global Medical Cures™ | Treatment of Atrial Fibrillation
DISCLAIMER-
Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
Computer Decision Support Systems and Electronic Health Records: Am J Pub Hea...Lorenzo Moja
We systematically reviewed randomized controlled trials (RCTs) assessing the ef- fectiveness of computerized decision support systems (CDSSs) featuring rule- or algorithm-based software integrated with electronic health records (EHRs) and evidence-based knowledge. We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Cochrane Database of Abstracts of Reviews of Effects. Information on system design, capabilities, acquisition, implementation context, and effects on mortality, morbidity, and economic outcomes were extracted.
Twenty-eight RCTs were included. CDSS use did not affect mortality (16 trials, 37395 patients; 2282 deaths; risk ratio [RR] = 0.96; 95% con- fidence interval [CI]=0.85, 1.08; I2 = 41%). A statistically significant effect was evident in the prevention of morbidity, any disease (9 RCTs; 13868 patients; RR = 0.82; 95% CI = 0.68, 0.99; I2 = 64%), but selective outcome reporting or publication bias cannot be excluded. We observed differences for costs and health service utilization, although these were often small in magnitude.
Across clinical settings, new generation CDSSs integrated with EHRs do not affect mortality and might moderately improve morbidity outcomes. (Am J Pub- lic Health. Published online ahead of print October 16, 2014: e1–e11. doi:10.2105/ AJPH.2014.302164)
Global Medical Cures™ | Stroke Prevention in Atrial Fibrillation
DISCLAIMER-
Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
Great article on how to integrate machine learning and optimization technique.
One group of researchers was able to reduce heart failure readmissions by 35% by combining machine learning and decision science technique, see "Data-driven decisions for reducing readmissions for heart failure: general methodology and case study" (Bayati, et. al., 2014).
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
Operation “Blue Star” is the only event in the history of Independent India where the state went into war with its own people. Even after about 40 years it is not clear if it was culmination of states anger over people of the region, a political game of power or start of dictatorial chapter in the democratic setup.
The people of Punjab felt alienated from main stream due to denial of their just demands during a long democratic struggle since independence. As it happen all over the word, it led to militant struggle with great loss of lives of military, police and civilian personnel. Killing of Indira Gandhi and massacre of innocent Sikhs in Delhi and other India cities was also associated with this movement.
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
Palestine last event orientationfvgnh .pptxRaedMohamed3
An EFL lesson about the current events in Palestine. It is intended to be for intermediate students who wish to increase their listening skills through a short lesson in power point.
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
2. Overview
Composite end point consists of two or more
component outcomes
Participants that experience any of the events are
considered to experience the composite outcome
3. Advantages
Statistical efficiency
Prevents arbitrary selection between different
outcomes from a single disease process
Broader evaluation of clinical benefit from an
intervention
4. Disadvantages
Misleading – assumes the effect on the composite
outcome is similar amongst components
Components can be of dissimilar importance
Post hoc changes to the composite
11. Critically assessing composite endpoints
Components are of similar importance to the
patient
Components occur with similar frequency
Components are affected to a similar degree
12. Sources
Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J
Med. 2011;365(26):2453-62.
Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes
in randomized trials: comparison of protocols to published articles. JAMA. 2004;291(20):2457-65.
Cordoba G, Schwartz L, Woloshin S, Bae H, Gøtzsche PC. Definition, reporting, and interpretation of composite
outcomes in clinical trials: systematic review. BMJ. 2010;341:c3920.
Gever J. Debate Surges on Composite Endpoints. MedPage Today. http://webcache.googleusercontent.com/search?
q=cache:KtUYRHXvqQQJ:www.medpagetoday.com/publichealthpolicy/clinicaltrials/18046
&cd=13&hl=en&ct=clnk&gl=us. Published January 19, 2010. Accessed February 12, 2017.
Kleist P. Composite Endpoints: Proceed with Caution. Applied Clinical Trials. http://
www.appliedclinicaltrialsonline.com/composite-endpoints-proceed-caution?id=&pageID=1&sk=&date=.
Published May 1, 2006. Accessed February 13, 2017.Montori VM, Jaeschke R, Schünemann HJ, et al. Users'
guide to detecting misleading claims in clinical research reports. BMJ. 2004;329(7474):1093-6.
Pearce W, Raman S, Turner A. Randomised trials in context: practical problems and social aspects of evidence-based
medicine and policy. Trials. 2015;16:394.
Rind D. Composite Endpoints and the CREST Trial. Evidence in Medicine. http://www.evidenceinmedicine.org/
2010/05/composite-endpoints-and-the-crest-trial.html. Published May 30, 2010. Accessed February 12, 2017.
Sankoh AJ, Li H, D'agostino RB. Use of composite endpoints in clinical trials. Stat Med. 2014;33(27):4709-14.
Tomlinson G, Detsky AS. Composite end points in randomized trials: there is no free lunch. JAMA. 2010;303(3):267-8.
Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a
randomised trial. Lancet. 2001;358(9286):951-7.
Editor's Notes
Higher event rates reduce the sample size requirement, cost, and time
Hypertension – can cause MI, CVA, etc
